CSA
TGTX icon

Cornerstone Select Advisors’s TG Therapeutics TGTX Stock Holding History

Cornerstone Select Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21M Sell
40,217
-6,691
-14% -$274K 0.93% 36
2026
Q1 		$1.56M Sell
46,908
-7,177
-13% -$214K 0.98% 36
2025
Q4 		$1.61M Sell
54,085
-1,199
-2% -$39.2K 1.12% 34
2025
Q3 		$2M Buy
55,284
+2,280
+4% +$75.1K 1.47% 24
2025
Q2 		$1.91M Sell
53,004
-3,298
-6% -$123K 1.68% 18
2025
Q1 		$2.22M Sell
56,302
-6,968
-11% -$234K 2.1% 9
2024
Q4 		$1.9M Buy
+63,270
New +$1.82M 1.84% 12

Other funds holding TGTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Cornerstone Select Advisors's TGTX Position: Q2 2026 in Review

Cornerstone Select Advisors reduced its TG Therapeutics (TGTX) stake by 14% in Q2 2026, selling an estimated $274K and leaving 40,217 shares worth $2.21M. The position accounts for 0.93% of the portfolio, ranked #36.

Cornerstone Select Advisors first reported a position in TGTX in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.22M in Q1 2025. 429 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Cornerstone Select Advisors held 40,217 shares of TG Therapeutics worth $2.21M as of Q2 2026.
  • Cornerstone Select Advisors sold 6,691 TG Therapeutics shares in Q2 2026, an estimated $274K.
  • TG Therapeutics made up 0.93% of Cornerstone Select Advisors's portfolio in Q2 2026, its #36 holding.
  • Cornerstone Select Advisors first reported a position in TG Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • Cornerstone Select Advisors's TG Therapeutics position peaked at $2.22M in Q1 2025.
  • 429 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Cornerstone Select Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.